# Expedition Therapeutics - funding rounds and investors

As of 14 Oct 2026, Expedition Therapeutics - has raised $165M across 1 verified round on record; latest: $165 million Series A led by Novo Holdings and Sofinnova Partners, announced 9 Oct 2025.

Expedition Therapeutics develops novel treatments for inflammatory and respiratory diseases, specifically targeting chronic obstructive pulmonary disease (COPD).

Website: https://expeditiontx.com  
Page: https://fireround.dev/companies/expeditiontx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-10-09 | Series A | $165 million | Novo Holdings, Sofinnova Partners | Adage Capital Management, Balyasny, BVF Partners, Dawn Biopharma, Forbion, Logos Fund, Sanofi Ventures, Venrock Healthcare Capital Partners | [businesswire.com](https://www.businesswire.com/news/home/20251009987148/en/Expedition-Therapeutics-Raises-%24165-Million-in-Oversubscribed-Series-A-Financing-to-Advance-Next-Generation-DPP1-inhibitor-for-COPD) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.